Hospice News July 21, 2023
Regulatory challenges have contributed to the hospice sector’s current M&A slump, but this year’s volume nevertheless aligns with experts’ forecasts.
In addition to those pressures, the industry is also in a cooling period in which companies focus on integrating the assets that many acquired during flurries of activity in 2021 and 2022, according to Mark Kulik, senior managing director at The Braff Group. Getting those “synergies” to align takes dedicated time and resources, Kulik stated.
Though the slowdown represents a change from prior years, some in the space have seen it coming.
“This year will be the second consecutive year-over-year decline in hospice activity. But if we were to analyze the first half of this year, hospice M&A is actually...
Today's Sponsors
Today's Sponsor